• Mohammad Saleem
  • Waseem Ahmad
  • Javed Sarwar
  • Fareeda Jamshed
  • Nasreen Gul
  • Muhammad Idrees


Background: Hepatitis C is a common problem in developing world. It can affect a large number ofasymptomatic people in whom it may cause serious complications in long run. Moreover, theseasymptomatic infected people pose a serious risk for the transmission of infection to healthy population.Objective of this study was to estimate the frequency of Hepatitis C in asymptomatic adult patientsattending medical OPD of District Headquarters Hospital Kotli, Azad Kashmir, and to assess the riskfactors associated with its transmission. Methods: This was a cross-sectional study that includedasymptomatic patients of both genders, aged 15–80 years, attending medical OPD of DistrictHeadquarter Hospital Kotli, Azad Kashmir from January to December, 2008. They attended the OPDfor problems other than Hepatitis and most of them presented with vague complaints like generalisedbody aches, tiredness and dyspeptic symptoms. They were randomly tested for Hepatitis C virus (HCV)antibodies by Immunochromatographic kit method. Positive samples for Hepatitis C antibodies wereconfirmed by third generation ELISA. Those who were confirmed were assessed for the risk factorsassociated with HCV transmission. Results: The study included 9,564 patients. Out of them 4,230(44.22%) were males and 5,334 (55.77%) were females. A total of 611 (6.38%) cases were positive forHCV; 257 (6.08%) were males, and 354 (6.64%) were females. Highest frequency (36%) was foundbetween 21 and 30 years of age, and 60.54% positive patients were 21–40 years old. Blood transfusionwas the most common (34.36%) risk factor followed by history of dental procedures (24.54%). In27.16% no risk factor could be detected. Conclusion: Frequency of Hepatitis C is quite high in ourpopulation. Rate is higher in young adults. It is needed to adopt organised preventive strategies toovercome this problem. Blood transfusion is still the most significant risk factor followed by dental andsurgical procedures. Health related procedures are still not safe in our set up and need to be addressed.Keywords: Hepatitis C, Asymptomatic


Umar M, Khaar HTB, Khurram M, Hasan Z. Anti-HCV

Antibody Positivity of various sections of Pakistani Patients. J

Coll Physicians Surg Pak 2009;19:737–41.

Ali A, Ahmad H, Ali I, Khan S, Zaidi G, Idrees M. Prevalence of

active Hepatitis c virus infection in district Mansehra Pakistan.

Virol J 2010;7:334.

Walsh K, GJM Alexander. Update on chronic viral Hepatitis.

Postgrad Med J 2001;77:498–505.

Dienstag JL. Acute viral Hepatitis. In: Fauci AS, Braunwald E,

Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J,

(editors). Harrison’s Principles of Internal Medicine. 17th ed. New

York: MacGraw-Hill; 2008.p.1940–1.

Umar M, Khaar HTB, editors. Hepatitis C in Pakistan.

Islamabad: SAF Publishers; 2006.

Syed T, Jamal MM: Epidemiology of Hepatitis C virus (HCV)

infection. Int J Med Sci 2006;3(2):41–6.

Al-Faleh FZ, Ramia S, Arif M, Ayoola EA, Al-Rashed RS, AlJeffry M, et al. Profile of Hepatitis C virus and the possible

modes of transmission of the virus in the Gizan area of Saudi

Arabia: a community-based study. Ann Trop Med Parasitol


El Guneid AM, Gunaid AA, O'Neill AM, Zureikat NI, Coleman

JC, Murray-Lyon IM. Prevalence of Hepatitis B, C and D virus

markers in Yemeni patients with chronic liver disease. J Med

Virol 1993;40:330–3.

Umar M, Khaar HTB, Anwaar AK, Mohsin A, Din W, Shah HA,

et al. Diagnosis, Management and prevention of Hepatitis C in

Pakistan 2009; PSG & PSH Consensus Guidelines 2009. p. 7–13.

Khattak MN, Akhtar S, Mahmud S, Roshan TM. Factors

influencing Hepatitis C virus sero-prevalence among blood

donors in North West Pakistan. J Public Health Policy


Tong CY, Khan R, Beeching NJ, Tariq WU, Hart CA, Ahmad N,

et al. The occurrence of Hepatitis B virus and HCV in Pakistani

patients with chronic liver disease and hepatocellular carcinoma.

Epidemiol Infect 1996;117:327–32.

Bari A, Akhtar S, Rahbar MH. Risk factors for Hepatitis C virus

infection in male adults in Rawalpindi-Islamabad, Pakistan. Trop

Med Int Health 2001;6:732–8.

Pérez CM, Suárez E, Torres EA, Román K, Colón V.

Seroprevalence of Hepatitis C virus and associated risk

behaviours: a population-based study in San Juan, Puerto Rico.

Int J Epidemiol 2005;34:593–9.

Muhammad N, Jan MA. Frequency of Hepatitis C in Buner,

NWFP. J Coll Physicians Surg Pak 2005;15:11–4.

Luby SP, Qamruddin K, Shah AA: The relationship between

therapeutic injections and high prevalence of Hepatitis C infection

in Hafizabad, Pakistan. Epidemiol Infect 1997;119:349–56.

Ali SS, Ali IS, Amir AM, Jadoon Z, Inayatullah S. Frequency of

Hepatitis-C infection in Diabetic Patients. J Ayub Med Coll

Abbottabad 2007;19(1):46–9.

Yen T, Keeffe EB, Ahmed A. The Epidemiology of Hepatitis C

Virus Infection. J Clin Gastroenterol 2003;36(1):47–53.

Effect of screening for Hepatitis C virus antibody and Hepatitis B

virus core antibody on incidence of post-transfusion Hepatitis.

Japanese Red Cross Non-A, Non-B Hepatitis Research Group.

Lancet 1991;338(8774):1040–1.

Donahue JG, Munoz A, Ness PM, Brown DE Jr, Yawn DH,

McAllister HA Jr, et al. The declining risk of post-transfusion

Hepatitis C virus infection. N Eng J Med 1992;327:369–73.

Soldan K, Barbara JA, Ramsay ME, Hall AJ. Estimation of the

risk of Hepatitis B virus, Hepatitis C virus and human

immunodeficiency virus infectious donations entering the blood

supply in England, 1993–2001. Vox Sang 2003;84(4):274–86.

Soza A, Arrese M, González R, Alvarez M, Pérez RM, Cortés P,

et al. Clinical and epidemiological features of 147 Chilean patients

with chronic Hepatitis C. Ann Hepatol 2004;3(4):146–51.

Kupek E. Transfusion risk for Hepatitis B, Hepatitis C and HIV

in the state of Santa Catarina, Brazil, 1991–2001. Braz J Infect

Dis 2004;8:236–40.



Most read articles by the same author(s)

1 2 3 > >>